406 Epizód

  1. Will New Tariffs Disrupt Your Next Pharma Deal?

    Közzétéve: 2025. 02. 26.

  2. Protecting Patient Data in a Changing Regulatory Landscape

    Közzétéve: 2025. 02. 25.

  3. Off-Label Promotion Changes in 2025

    Közzétéve: 2025. 02. 24.

  4. Turning Physicians into Leaders

    Közzétéve: 2025. 02. 21.

  5. Key Regulatory Agencies in Pharma M&A

    Közzétéve: 2025. 02. 20.

  6. Does E6 (R3) Blur the Line Between GCP and Privacy Laws?

    Közzétéve: 2025. 02. 19.

  7. RFK Jr. Confirmed as HHS Secretary: What It Means for Healthcare Policy

    Közzétéve: 2025. 02. 18.

  8. America’s Research Future in Jeopardy

    Közzétéve: 2025. 02. 15.

  9. Trump Administration’s NIH cuts: Will they cripple US medical research?

    Közzétéve: 2025. 02. 14.

  10. DEI Under Trump: What It Means for Clinical Trials

    Közzétéve: 2025. 02. 13.

  11. CAPA & RCA: A Must for Pharma M&A

    Közzétéve: 2025. 02. 12.

  12. Trump Targets Indirect Costs in NIH Funding

    Közzétéve: 2025. 02. 11.

  13. The USAID Halt and Its Consequences for Clinical Research

    Közzétéve: 2025. 02. 10.

  14. Ebola Vaccine Trial in Record Time!

    Közzétéve: 2025. 02. 08.

  15. Your Clinical Trial Site M&A Agreement is Exposing You to Risk

    Közzétéve: 2025. 02. 07.

  16. What Does ICH E6 R3 Say About Returning Data to Participants?

    Közzétéve: 2025. 02. 05.

  17. Navigating the Ongoing HHS Communication Freeze

    Közzétéve: 2025. 02. 04.

  18. Ordinary People Are Changing Medicine

    Közzétéve: 2025. 02. 03.

  19. Trump’s First 10 Days: The Impact on Clinical Trials

    Közzétéve: 2025. 01. 31.

  20. Selling a Business with Issues

    Közzétéve: 2025. 01. 31.

2 / 21

Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm -  Helping regulators see your business the way you do. We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career. 

Visit the podcast's native language site